Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,822,278
-$3,396,417 QoQ
Shares Held
397,221
-41.1% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#57
of 245 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ArrowMark Colorado Holdings LLC holds $294,624,620 across 32 Biotechnology names. DYN ranks #13 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
4,105,095 | $32,224,995 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
564,069 | $26,533,805 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
767,383 | $22,898,708 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
708,385 | $22,144,115 | |
| 5 | RPRX |
Royalty Pharma plc
|
366,199 | $20,532,777 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
46,030 | $15,410,383 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
573,318 | $14,550,810 | |
| 8 | CGON |
CG Oncology, Inc.
|
155,354 | $11,037,901 |
All Filings in DYN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,822,278 | 397,221 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,218,695 | 673,949 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,704,772 | 700,653 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,941,824 | 785,915 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,332,542 | 770,225 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,392,515 | 897,946 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,963,362 | 932,231 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,334,824 | 900,190 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,446,190 | 919,416 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,856,790 | 382,416 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,086,132 | 382,416 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,426,447 | 382,416 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,302,180 | 382,416 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,169,889 | 275,164 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,189,150 | 275,164 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,494,582 | 275,164 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,157,595 | 168,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,624,340 | 168,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,003,465 | 168,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,736,440 | 168,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,545,240 | 168,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,553,000 | 100,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,100,000 | 100,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,038,000 | 200,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||